<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01597427</url>
  </required_header>
  <id_info>
    <org_study_id>UNIFESP-02</org_study_id>
    <nct_id>NCT01597427</nct_id>
  </id_info>
  <brief_title>Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery</brief_title>
  <official_title>Intravenous Clonidine Does Not Reduce Pulmonary Artery Pressure in Patients Subjected to Cardiac</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the ability of clonidine to reduce the mean pulmonary
      artery pressure in patients with pulmonary hypertension subjected to cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, clinical-interventionist, randomized, and double-blind study. Patients with
      group 2 pulmonary hypertension will be included and subjected to cardiac surgery with
      extracorporeal circulation. Mean pulmonary artery pressure and the doses of dobutamine and
      sodium nitroprusside will be assessed four times: before (T0) administration of 2 μg/kg of
      intravenous clonidine or a placebo, 30 minutes after the onset of treatment (T1), immediately
      after extracorporeal circulation (T2), and 10 minutes after the injection of protamine (T3).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction pulmonary artery pressure</measure>
    <time_frame>During intraoperative (hours)</time_frame>
    <description>Assessed four times: before (T0) administration of 2 μg·kg-1 of intravenous clonidine or a placebo, 30 minutes after the onset of treatment (T1), immediately after ECC (T2), and 10 minutes after the injection of protamine (T3).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Doses of Dobutamine</measure>
    <time_frame>During intraoperative (hours)</time_frame>
    <description>Evaluate the need for using and dose of dobutamine immediately after extracorporeal circulation between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doses of Sodium nitroprusside</measure>
    <time_frame>During intraoperative (hours)</time_frame>
    <description>Evaluate the need for using and dose of sodium nitroprusside immediately after extracorporeal circulation between groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Clonidine</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Administration of 2 μg/kg of intravenous clonidine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Injection of placebo solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>Administration of 2 μg/kg of intravenous clonidine</description>
    <arm_group_label>Clonidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Injection of placebo solution.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signing an informed consent form,

          -  Aged 18 to 80 years

          -  Pulmonary hypertension due to left heart disease,

          -  Physical status 2 or 3 according to the classification system of the American Society
             of Anesthesiologists,

          -  Subjected to cardiac circulation with extracorporeal circulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luiz Fernando R Falcao, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benedito B Joao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Luiz Fernando dos Reis Falcao</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04024-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2012</study_first_posted>
  <last_update_submitted>May 10, 2012</last_update_submitted>
  <last_update_submitted_qc>May 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Luiz Fernando dos Reis Falcao</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Clonidine</keyword>
  <keyword>Hypertension Pulmonary</keyword>
  <keyword>Cardiac Surgical Procedures</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

